Back to Search Start Over

P1.01-107 The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303).

Authors :
Si, X.
Zhang, L.
Wang, H.
Zhang, X.
Wang, M.
Han, B.
Li, K.
Wang, Q.
Shi, J.
Wang, Z.
Cheng, Y.
He, J.
Shi, Y.
Chen, W.
Wang, X.
Luo, Y.
Nan, K.
Jin, F.
Li, B.
Chen, Y.
Source :
Journal of Thoracic Oncology; Oct2018 Supplement, Vol. 13, pS505-S505, 1p
Publication Year :
2018

Details

Language :
English
ISSN :
15560864
Volume :
13
Database :
Complementary Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Academic Journal
Accession number :
132778861
Full Text :
https://doi.org/10.1016/j.jtho.2018.08.664